— Know what they know.
Not Investment Advice
Also trades as: TEVA (NYSE) · $vol 221M · TEVA.TA (TLV) · $vol 41M

TEVJF OTC

Teva Pharmaceutical Industries Limited
1W: +18.5% 1M: +5.3% 3M: +28.5% YTD: +36.2% 1Y: +172.2% 3Y: +392.8% 5Y: +233.2%
$38.98
+1.98 (+5.35%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 64 · $45.4B mcap · 1.11B float · 0.0000% daily turnover · Short 88% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 12Hold: 23Sell: 4Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$—
Analysts0

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 40 Grade C
Profitability
25
Balance Sheet
24
Earnings Quality
72
Growth
60
Value
28
Momentum
87
Safety
15
Cash Flow
57
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TEVJF scores highest in Momentum (87/100) and lowest in Safety (15/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.71
Distress Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓
Beneish M-Score
-2.72
Unlikely Manipulator
Ohlson O-Score
-6.94
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
B
Score: 29.4/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 3.17x
Accruals: -3.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TEVJF scores 0.71, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TEVJF scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TEVJF's score of -2.72 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TEVJF's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TEVJF receives an estimated rating of B (score: 29.4/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). TEVJF's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
63.18x
PEG
0.11x
P/S
2.66x
P/B
5.98x
P/FCF
34.01x
P/OCF
15.79x
EV/EBITDA
16.47x
EV/Revenue
2.83x
EV/EBIT
25.72x
EV/FCF
46.55x
Earnings Yield
2.00%
FCF Yield
2.94%
Shareholder Yield
0.00%
Graham Number
$9.46
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 63.2x earnings, TEVJF is priced for high growth expectations. Graham's intrinsic value formula yields $9.46 per share, 312% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.994
NI / EBT
×
Interest Burden
0.378
EBT / EBIT
×
EBIT Margin
0.110
EBIT / Rev
×
Asset Turnover
0.433
Rev / Assets
×
Equity Multiplier
5.485
Assets / Equity
=
ROE
9.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TEVJF's ROE of 9.8% is driven by financial leverage (equity multiplier: 5.48x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 0.99 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$5.15
Price/Value
5.89x
Margin of Safety
-488.84%
Premium
488.84%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with TEVJF's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. TEVJF trades at a 489% premium to its adjusted intrinsic value of $5.15, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 63.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$38.98
Median 1Y
$30.81
5th Pctile
$7.41
95th Pctile
$127.92
Ann. Volatility
85.2%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Richard Francis
President and Chief Executive Officer
$1,700,000 $11,999,970 $19,168,709
Evan Lippman President,
Vice President, Business Development
$496,923 $4,899,975 $7,222,009
Eli Kalif President,
Vice President, Chief Financial Officer
$1,012,687 $3,799,989 $6,961,991
Dr. Eric Hughes
Executive Vice President, Global R&D and Chief Medical Officer
$829,231 $3,749,983 $6,298,933
Christine Fox President,
Vice President, US Commercial
$849,231 $3,399,977 $5,895,161

CEO Pay Ratio

164:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $19,168,709
Avg Employee Cost (SGA/emp): $117,025
Employees: 33,950

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
33,950
-7.8% YoY
Revenue / Employee
$550,259
Rev: $18,681,281,000
Profit / Employee
$44,989
NI: $1,527,366,000
SGA / Employee
$117,025
Avg labor cost proxy
R&D / Employee
$32,299
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 7.2% 4.1% -6.4% -10.9% -13.4% -25.9% -18.8% -27.9% -28.3% -7.5% -6.5% -7.1% -15.3% -25.5% -19.0% -2.4% 10.7% 21.4% 21.7% 9.8% 9.82%
ROA 1.5% 0.8% -1.3% -2.2% -2.8% -5.1% -3.6% -5.1% -5.2% -1.3% -1.1% -1.1% -2.4% -4.0% -3.2% -0.4% 1.7% 3.5% 4.0% 1.8% 1.79%
ROIC 4.9% 3.7% 1.5% -2.6% -3.3% -6.2% -4.1% -3.4% -3.7% 1.4% 0.7% 2.9% 1.6% -1.2% 1.6% 3.2% 6.1% 16.7% 17.5% 12.3% 12.30%
ROCE 6.0% 6.8% 3.7% -0.6% -1.2% -6.6% -4.3% -3.7% -4.0% 1.2% 0.6% 2.9% 1.5% -1.1% 1.7% 3.1% 6.3% 7.0% 8.1% 7.9% 7.88%
Gross Margin 46.1% 50.0% 47.5% 47.4% 46.4% 45.6% 43.2% 46.3% 48.1% 54.2% 46.4% 48.6% 49.6% 50.1% 48.2% 50.3% 51.4% 56.4% 49.5% 52.0% 51.98%
Operating Margin 16.0% 1.9% -19.5% -25.1% 11.7% -22.0% -0.4% -16.7% 9.2% 16.2% -5.7% -0.1% -1.2% -0.7% 13.3% 10.9% 19.7% 27.5% 16.4% -5.6% -5.58%
Net Margin 7.5% -3.9% -26.1% -6.1% 1.6% -31.4% -6.0% -22.3% 2.1% 9.6% -3.6% -20.3% -10.1% -5.1% 5.5% 6.8% 9.7% 10.4% 9.3% -13.9% -13.91%
EBITDA Margin 24.5% 28.2% -10.7% -15.6% 20.6% -15.1% 8.0% -9.2% 16.3% 21.5% 1.4% 6.1% 4.8% 6.2% 19.6% 15.7% 24.7% 9.8% 25.2% 9.9% 9.85%
FCF Margin 0.5% 1.5% 3.8% 3.1% 3.4% 7.0% 6.5% 7.8% 4.0% 5.3% 5.5% 4.2% 8.2% 4.5% 4.6% 5.4% 3.4% 4.9% 5.1% 6.1% 6.09%
OCF Margin 4.1% 5.0% 7.4% 6.9% 7.1% 10.7% 10.0% 11.3% 7.6% 8.6% 8.7% 7.2% 11.1% 7.5% 7.6% 8.4% 6.4% 11.7% 12.0% 13.1% 13.10%
ROE 3Y Avg snapshot only -0.19%
ROE 5Y Avg snapshot only -8.82%
ROA 3Y Avg snapshot only 0.08%
ROIC 3Y Avg snapshot only 3.29%
ROIC Economic snapshot only 10.62%
Cash ROA snapshot only 5.69%
Cash ROIC snapshot only 10.82%
CROIC snapshot only 5.02%
NOPAT Margin snapshot only 14.90%
Pretax Margin snapshot only 4.16%
R&D / Revenue snapshot only 9.90%
SGA / Revenue snapshot only 23.83%
SBC / Revenue snapshot only 0.97%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 15.00 22.88 -16.65 -8.00 -6.94 -4.22 -5.45 -3.50 -5.20 -16.84 -31.89 -34.99 -20.31 -12.79 -13.34 -130.80 32.71 23.65 21.24 50.05 63.184
P/S Ratio 0.67 0.60 0.66 0.55 0.59 0.67 0.59 0.52 0.76 0.61 0.98 1.02 1.20 1.27 1.03 1.24 1.39 1.94 1.93 2.07 2.664
P/B Ratio 1.04 0.93 1.10 0.93 1.02 1.26 1.12 1.12 1.67 1.29 2.16 2.62 3.33 3.90 2.74 3.03 3.21 4.24 4.06 4.62 5.981
P/FCF 123.75 40.43 17.50 17.72 17.42 9.53 9.15 6.71 19.00 11.48 17.91 24.53 14.74 27.98 22.42 23.22 40.30 39.31 38.10 34.01 34.008
P/OCF 16.18 11.96 8.87 7.97 8.34 6.25 5.90 4.65 9.99 7.06 11.32 14.26 10.87 16.81 13.55 14.87 21.85 16.61 16.04 15.79 15.791
EV/EBITDA 9.23 8.10 12.04 25.56 30.98 -34.65 -189.81 291.34 -1345.60 17.45 25.38 17.57 24.47 46.00 21.81 19.08 13.70 15.86 14.44 16.47 16.467
EV/Revenue 2.03 1.94 2.02 1.87 1.87 1.92 1.86 1.75 1.94 1.68 2.04 2.05 2.15 2.16 1.95 2.17 2.28 2.75 2.69 2.83 2.833
EV/EBIT 15.19 12.45 23.61 -142.73 -69.65 -13.43 -19.31 -22.98 -24.36 71.67 196.80 40.83 86.01 -126.74 71.36 41.65 21.52 24.91 21.71 25.72 25.719
EV/FCF 375.20 130.66 53.63 60.57 55.15 27.54 28.75 22.35 48.69 31.58 37.21 49.07 26.41 47.72 42.35 40.48 66.05 55.51 53.10 46.55 46.554
Earnings Yield 6.7% 4.4% -6.0% -12.5% -14.4% -23.7% -18.3% -28.6% -19.2% -5.9% -3.1% -2.9% -4.9% -7.8% -7.5% -0.8% 3.1% 4.2% 4.7% 2.0% 2.00%
FCF Yield 0.8% 2.5% 5.7% 5.6% 5.7% 10.5% 10.9% 14.9% 5.3% 8.7% 5.6% 4.1% 6.8% 3.6% 4.5% 4.3% 2.5% 2.5% 2.6% 2.9% 2.94%
PEG Ratio snapshot only 0.115
EV/OCF snapshot only 21.617
EV/Gross Profit snapshot only 5.399
Acquirers Multiple snapshot only 18.886
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $9.46
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.03 1.14 1.07 1.11 0.99 1.05 1.10 1.02 1.00 1.02 0.89 0.89 0.89 0.98 1.03 1.06 1.11 1.04 1.01 0.88 0.879
Quick Ratio 0.68 0.79 0.73 0.74 0.66 0.72 0.71 0.67 0.65 0.69 0.61 0.59 0.61 0.75 0.74 0.77 0.82 0.80 0.78 0.67 0.674
Debt/Equity 2.31 2.28 2.49 2.48 2.47 2.73 2.68 2.98 2.93 2.68 2.74 2.98 3.18 3.36 2.71 2.57 2.36 2.20 2.05 2.18 2.175
Net Debt/Equity 2.11 2.07 2.26 2.26 2.21 2.38 2.40 2.60 2.60 2.26 2.33 2.62 2.63 2.75 2.43 2.25 2.05 1.75 1.60 1.70 1.704
Debt/Assets 0.51 0.49 0.50 0.49 0.49 0.49 0.48 0.49 0.48 0.46 0.47 0.46 0.46 0.46 0.44 0.44 0.43 0.43 0.42 0.42 0.423
Debt/EBITDA 6.75 6.16 8.94 19.91 23.63 -26.04 -144.08 233.51 -922.64 13.22 15.49 9.98 13.06 23.27 11.41 9.28 6.13 5.82 5.24 5.66 5.665
Net Debt/EBITDA 6.18 5.59 8.11 18.08 21.20 -22.66 -129.40 203.86 -820.41 11.11 13.17 8.79 10.81 19.02 10.26 8.14 5.34 4.63 4.08 4.44 4.438
Interest Coverage 1.86 2.60 1.45 -0.23 -0.45 -2.27 -1.52 -1.14 -1.18 0.35 0.16 0.79 0.41 -0.28 0.46 0.92 2.03 2.86 3.28 2.68 2.675
Equity Multiplier 4.57 4.64 5.04 5.08 5.05 5.57 5.53 6.11 6.07 5.79 5.88 6.50 6.89 7.32 6.13 5.88 5.50 5.15 4.86 5.14 5.138
Cash Ratio snapshot only 0.234
Debt Service Coverage snapshot only 4.179
Cash to Debt snapshot only 0.217
FCF to Debt snapshot only 0.062
Defensive Interval snapshot only 402.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.33 0.32 0.32 0.32 0.33 0.33 0.33 0.34 0.35 0.36 0.37 0.39 0.40 0.40 0.41 0.41 0.41 0.43 0.44 0.43 0.433
Inventory Turnover 1.99 2.02 1.92 1.92 1.97 2.08 2.00 2.01 2.09 2.09 2.03 2.05 2.10 2.41 2.35 2.26 2.30 2.69 2.59 2.45 2.450
Receivables Turnover 3.85 3.49 3.53 3.45 3.89 3.63 3.88 3.75 4.29 4.46 4.64 4.46 4.90 5.12 4.86 4.54 4.61 5.10 5.11 4.91 4.907
Payables Turnover 5.35 4.81 4.71 4.67 5.01 4.45 3.93 3.72 4.23 3.65 3.39 3.38 3.62 3.53 3.57 3.45 3.54 3.51 3.40 3.15 3.154
DSO 95 105 104 106 94 101 94 97 85 82 79 82 75 71 75 80 79 72 71 74 74.4 days
DIO 183 181 190 191 186 176 183 182 174 175 180 178 174 151 155 162 159 136 141 149 149.0 days
DPO 68 76 78 78 73 82 93 98 86 100 108 108 101 103 102 106 103 104 107 116 115.7 days
Cash Conversion Cycle 210 210 216 218 207 194 184 181 173 157 151 152 147 119 128 136 135 103 105 108 107.6 days
Fixed Asset Turnover snapshot only 4.064
Operating Cycle snapshot only 223.4 days
Cash Velocity snapshot only 4.737
Capital Intensity snapshot only 2.302
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -2.7% -4.7% -4.5% -5.4% -6.7% -6.0% -4.0% -2.7% 0.9% 6.2% 7.2% 8.5% 9.8% 4.4% 3.8% 2.1% 0.0% 4.3% 4.4% 4.1% 4.14%
Net Income 1.2% 1.1% 84.6% 73.1% -2.8% -6.6% -1.6% -1.1% -72.4% 75.6% 69.5% 78.8% 55.4% -1.9% -1.6% 66.8% 1.7% 1.9% 2.2% 5.5% 5.53%
EPS 1.2% 1.1% 84.6% 73.1% -2.8% -6.6% -1.6% -1.1% -70.0% 75.8% 69.7% 79.1% 55.3% -1.8% -1.5% 67.6% 1.7% 1.8% 2.2% 5.5% 5.45%
FCF -87.5% -63.0% 7.2% 4.6% 4.8% 3.4% 64.8% 1.5% 18.3% -19.2% -8.9% -42.1% 1.2% -11.0% -12.9% 31.1% -57.7% 14.0% 14.7% 18.4% 18.39%
EBITDA 2.6% 3.0% 2.6% 1.8% -74.4% -1.2% -1.1% -92.0% -1.0% 2.8% 9.8% 20.1% 68.1% -49.0% 15.4% -0.4% 88.8% 2.8% 1.2% 57.8% 57.78%
Op. Income 1.5% 1.5% 1.2% 67.1% -1.6% -2.2% -3.5% -13.9% 0.5% 1.2% 1.2% 1.8% 1.4% -1.7% 1.0% 4.7% 3.1% 11.4% 6.6% 1.9% 1.91%
OCF Growth snapshot only 63.24%
Asset Growth snapshot only -0.68%
Equity Growth snapshot only 13.62%
Debt Growth snapshot only -3.70%
Shares Change snapshot only 1.72%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -6.3% -5.6% -4.9% -4.5% -4.6% -4.9% -5.0% -4.0% -2.9% -1.6% -0.6% -0.1% 1.1% 1.4% 2.2% 2.5% 3.5% 5.0% 5.1% 4.9% 4.86%
Revenue 5Y -4.4% -6.2% -7.3% -8.0% -8.4% -7.8% -7.3% -6.3% -5.0% -3.4% -2.4% -1.7% -0.8% -1.0% -0.9% -0.4% 0.1% 0.7% 1.3% 1.2% 1.19%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y -17.4% 14.0% — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y -15.4% 15.9% — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — 68.6% — — — — — -65.0% — — — — -25.6% -41.1% -17.1% 18.7% 45.0% — — 2.2% 2.21%
EBITDA 5Y -2.4% -0.3% -7.1% — — — — — — 13.9% — — — -10.3% 1.9% -2.1% — — — — —
Gross Profit 3Y -5.4% -3.3% -1.9% -1.6% -1.3% -2.6% -4.2% -3.6% -2.9% -0.3% 1.3% 1.8% 3.3% 2.0% 3.1% 3.8% 5.0% 8.6% 9.8% 10.0% 10.04%
Gross Profit 5Y -7.7% -8.5% -8.9% -9.0% -9.1% -8.4% -8.0% -6.6% -4.8% -1.9% -0.2% 0.8% 2.1% 1.4% 1.1% 1.6% 1.9% 3.0% 3.7% 3.5% 3.50%
Op. Income 3Y — — — — — — — — — — — — -39.7% — -8.7% — — — — — —
Op. Income 5Y -8.7% -4.4% -21.3% — — — — — — — — — — — — 15.7% — — — — —
FCF 3Y -67.5% -49.2% 9.2% 78.3% — 2.4% 64.4% 18.9% -4.9% 9.7% — — 1.5% 47.0% 9.4% 23.2% 4.0% -6.4% -3.1% -3.5% -3.51%
FCF 5Y -54.7% -44.1% -29.6% -31.5% -28.8% -16.9% -23.6% -18.1% -24.9% -14.0% 14.4% 51.9% — 94.4% 28.7% 5.0% -3.9% 6.0% — — —
OCF 3Y -40.9% -31.2% 2.8% 16.3% 23.0% 18.4% 9.1% 0.9% -10.9% 4.0% 40.0% 37.3% 40.2% 16.0% 3.1% 9.5% -0.2% 8.3% 11.8% 10.2% 10.21%
OCF 5Y -34.1% -31.3% -23.2% -23.7% -22.2% -14.6% -19.9% -15.6% -18.7% -11.0% 5.5% 11.7% 26.3% 5.4% 1.9% -3.4% -8.2% 10.7% 32.7% 38.1% 38.14%
Assets 3Y -9.7% -7.7% -7.7% -8.2% -8.2% -8.5% -7.7% -7.8% -5.4% -5.0% -4.4% -5.6% -4.4% -6.2% -6.5% -4.4% -3.4% -2.5% -2.7% -2.6% -2.57%
Assets 5Y -13.5% -12.5% -12.4% -11.9% -12.5% -9.0% -8.9% -8.5% -8.3% -6.5% -6.5% -7.0% -6.1% -7.3% -7.0% -6.1% -4.3% -4.2% -4.0% -4.1% -4.12%
Equity 3Y -16.1% -11.3% -14.1% -13.8% -14.0% -17.3% -16.6% -20.2% -10.3% -9.2% -10.0% -14.9% -16.6% -19.4% -12.5% -8.9% -6.1% 0.1% 1.6% 3.2% 3.23%
Book Value 3Y -18.5% -13.2% -14.5% -14.3% -14.7% -17.7% -17.0% -20.6% -11.3% -9.9% -10.5% -15.5% -17.2% -20.2% -13.8% -10.3% -7.4% -1.7% -0.3% 1.4% 1.42%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.90 0.97 0.93 0.88 0.87 0.91 0.92 0.92 0.90 0.79 0.66 0.51 0.23 0.18 0.11 0.01 0.04 0.12 0.31 0.31 0.313
Earnings Stability 0.01 0.11 0.09 0.48 0.59 0.43 0.50 0.43 0.57 0.09 0.30 0.17 0.28 0.02 0.09 0.09 0.27 0.38 0.63 0.79 0.791
Margin Stability 0.90 0.91 0.93 0.94 0.95 0.96 0.97 0.97 0.98 0.97 0.96 0.95 0.95 0.95 0.96 0.95 0.96 0.96 0.95 0.94 0.944
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.000
FCF Positive Streak 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.20 0.20 0.50 0.50 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.42 0.28 0.16 0.07 0.03 -0.12 0.03 -0.07 -0.28 0.05 0.07 0.14 0.07 -0.12 -0.07 0.17 0.34 0.37 0.33 0.14 0.141
Gross Margin Trend 0.02 0.03 0.03 0.02 0.02 -0.00 -0.01 -0.02 -0.02 0.01 0.02 0.03 0.03 0.01 0.02 0.02 0.02 0.03 0.03 0.03 0.029
FCF Margin Trend -0.01 -0.01 0.03 0.01 0.01 0.04 0.05 0.07 0.02 0.01 0.00 -0.01 0.04 -0.02 -0.01 -0.01 -0.03 0.00 0.00 0.01 0.013
Sustainable Growth Rate 7.2% 4.1% — — — — — — — — — — — — — — 10.7% 21.4% 21.7% 9.8% 9.82%
Internal Growth Rate 1.5% 0.9% — — — — — — — — — — — — — — 1.8% 3.7% 4.2% 1.8% 1.82%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.93 1.91 -1.88 -1.00 -0.83 -0.68 -0.92 -0.75 -0.52 -2.38 -2.82 -2.45 -1.87 -0.76 -0.98 -8.80 1.50 1.42 1.32 3.17 3.170
FCF/OCF 0.13 0.30 0.51 0.45 0.48 0.66 0.65 0.69 0.53 0.62 0.63 0.58 0.74 0.60 0.60 0.64 0.54 0.42 0.42 0.46 0.464
FCF/Net Income snapshot only 1.472
OCF/EBITDA snapshot only 0.762
CapEx/Revenue 3.6% 3.5% 3.7% 3.8% 3.7% 3.7% 3.6% 3.5% 3.6% 3.3% 3.2% 3.0% 2.9% 3.0% 3.0% 3.0% 2.9% 2.9% 3.1% 3.2% 3.18%
CapEx/Depreciation snapshot only 0.513
Accruals Ratio 0.00 -0.01 -0.04 -0.04 -0.05 -0.09 -0.07 -0.09 -0.08 -0.04 -0.04 -0.04 -0.07 -0.07 -0.06 -0.04 -0.01 -0.02 -0.01 -0.04 -0.039
Sloan Accruals snapshot only -0.093
Cash Flow Adequacy snapshot only 4.126
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.75 0.63 1.35 0.55 0.60 0.77 0.68 1.06 1.01 0.90 0.59 2.90 1.77 1.28 2.48 2.23 0.79 1.15 1.14 0.99 0.994
Interest Burden (EBT/EBIT) 0.45 0.27 -0.34 9.52 5.26 1.43 1.65 1.86 1.82 -1.72 -5.02 -0.20 -1.33 4.54 -1.14 -0.08 0.51 0.65 0.64 0.38 0.378
EBIT Margin 0.13 0.16 0.09 -0.01 -0.03 -0.14 -0.10 -0.08 -0.08 0.02 0.01 0.05 0.03 -0.02 0.03 0.05 0.11 0.11 0.12 0.11 0.110
Asset Turnover 0.33 0.32 0.32 0.32 0.33 0.33 0.33 0.34 0.35 0.36 0.37 0.39 0.40 0.40 0.41 0.41 0.41 0.43 0.44 0.43 0.433
Equity Multiplier 4.86 4.84 4.97 4.91 4.79 5.04 5.26 5.53 5.50 5.68 5.70 6.30 6.45 6.43 6.00 6.18 6.13 6.03 5.41 5.48 5.485
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.65 $0.38 $-0.56 $-0.95 $-1.15 $-2.12 $-1.45 $-2.01 $-1.96 $-0.51 $-0.44 $-0.42 $-0.88 $-1.45 $-1.11 $-0.14 $0.61 $1.21 $1.33 $0.61 $0.61
Book Value/Share $9.44 $9.32 $8.44 $8.14 $7.83 $7.11 $7.05 $6.30 $6.10 $6.70 $6.48 $5.61 $5.35 $4.74 $5.40 $5.88 $6.23 $6.74 $6.98 $6.57 $6.66
Tangible Book/Share $-15.82 $-15.62 $-16.04 $-14.86 $-14.35 $-14.41 $-14.26 $-14.11 $-13.64 $-13.43 $-13.17 $-13.22 $-13.08 $-12.53 $-11.57 $-11.42 $-10.85 $-10.12 $-9.50 $-9.76 $-9.76
Revenue/Share $14.63 $14.40 $14.05 $13.90 $13.53 $13.43 $13.39 $13.41 $13.46 $14.14 $14.25 $14.38 $14.80 $14.60 $14.34 $14.32 $14.41 $14.71 $14.72 $14.66 $14.94
FCF/Share $0.08 $0.21 $0.53 $0.43 $0.46 $0.94 $0.86 $1.05 $0.54 $0.75 $0.78 $0.60 $1.21 $0.66 $0.66 $0.77 $0.50 $0.73 $0.74 $0.89 $2.04
OCF/Share $0.61 $0.72 $1.04 $0.95 $0.96 $1.43 $1.34 $1.51 $1.02 $1.22 $1.24 $1.03 $1.64 $1.10 $1.09 $1.20 $0.92 $1.72 $1.77 $1.92 $2.52
Cash/Share $1.84 $1.96 $1.96 $1.85 $1.99 $2.52 $1.92 $2.38 $1.98 $2.88 $2.66 $1.99 $2.93 $2.91 $1.46 $1.86 $1.89 $3.03 $3.17 $3.09 $3.12
EBITDA/Share $3.23 $3.45 $2.35 $1.02 $0.82 $-0.75 $-0.13 $0.08 $-0.02 $1.36 $1.15 $1.67 $1.30 $0.69 $1.28 $1.63 $2.39 $2.55 $2.74 $2.52 $2.52
Debt/Share $21.80 $21.27 $21.06 $20.23 $19.32 $19.41 $18.87 $18.76 $17.88 $17.98 $17.75 $16.70 $17.01 $15.96 $14.62 $15.09 $14.68 $14.82 $14.34 $14.29 $14.29
Net Debt/Share $19.95 $19.31 $19.09 $18.37 $17.33 $16.89 $16.94 $16.38 $15.90 $15.10 $15.09 $14.71 $14.08 $13.04 $13.15 $13.23 $12.79 $11.79 $11.17 $11.19 $11.19
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.715
Altman Z-Prime snapshot only 0.041
Piotroski F-Score 5 7 7 5 4 3 4 4 6 6 6 6 7 4 6 7 8 8 7 7 7
Beneish M-Score -2.57 -2.58 -2.76 -2.73 -2.83 -3.05 -2.96 -3.12 -2.97 -2.83 -2.74 -2.64 -2.80 -2.94 -2.87 -2.75 -2.48 -2.43 -2.56 -2.72 -2.721
Ohlson O-Score snapshot only -6.937
Net-Net WC snapshot only $-15.53
EVA snapshot only $481589843.68
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B
Credit Score 25.70 28.20 22.20 17.20 15.85 21.70 21.70 13.60 21.70 19.70 18.35 18.35 17.75 14.35 19.70 20.60 29.40 31.00 34.45 29.35 29.350
Credit Grade snapshot only 15
Credit Trend snapshot only 8.750
Implied Spread (bps) snapshot only 750.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms